Management of Aamvata by Ayurvedic Treatment: A Case study
Department of Kayachikitsa, M. A. M.’s Sumatibhai Shah Ayurved Mahavidyalaya, Malwadi, Hadapsar, Pune- 411028, Maharashtra, India.
Case Study
World Journal of Advanced Research and Reviews, 2022, 16(03), 1067-1071
Article DOI: 10.30574/wjarr.2022.16.3.1430
Publication history:
Received on 15 November 2022; revised on 28 December 2022; accepted on 30 December 2022
Abstract:
Amavata is a disease caused due to the vitiation or aggravation of Vayu associated with Ama. Vitiated Vayu circulates the Ama all over the body through Dhamanies, takes shelter in the Shleshma Sthana (Amashaya, Sandhi, etc.), producing symptoms such as stiffness, swelling, and tenderness in small and big joints, making a person lame. The symptoms of Amavata are identical to rheumatism, which include rheumatoid arthritis and rheumatic fever. It is observed that rheumatism is an autoimmune disorder, which is among the collagen disorders having strong and significant parlance with Amavata. Various drug trials were already carried out on Amavata, yet there is a lacuna in the management of Amavata. Rheumatoid arthritis (RA), an auto-immune inflammatory disease is one of the challenging conditions for the physicians to handle due to its chronicity, incurability, complications, morbidity, etc. In spite of potent anti-inflammatory agents and powerful immune-suppressive agents, its prognosis is not good, as these drugs have certain limitations including dependency and other side effects restricting quality of life. Considering these inconveniences, alternatives are being searched from traditional systems. Ayurveda through its armamentarium can provide leads in the management of this condition that is similar to Amavata in its clinical presentation. A 42-year-old female with diagnosed history of RA was treated by Ayurvedic medicines then improvement was observed in the overall effect of therapy.
Keywords:
Amavata; Ama; Rheumatism; Amrita; Tinospora cordifolia; Ghee
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0